Ebola drug trial in Guinea 'encouraging': researchers
PARIS (AFP) - An Ebola candidate treatment yielded "encouraging" results in an early-stage trial with 80 patients in Guinea, with faster recovery rates reported, the French government and medical research agency Inserm said Thursday.
An Inserm statement to AFP said "encouraging results of the trial" with Japanese-manufactured anti-viral drug favipiravir "will be submitted shortly to a scientific journal for publication".
RELATED